TW577889B - Sulfonamide compound having hypoglycemic activity or PDE-V inhibitory activity - Google Patents

Sulfonamide compound having hypoglycemic activity or PDE-V inhibitory activity Download PDF

Info

Publication number
TW577889B
TW577889B TW088121089A TW88121089A TW577889B TW 577889 B TW577889 B TW 577889B TW 088121089 A TW088121089 A TW 088121089A TW 88121089 A TW88121089 A TW 88121089A TW 577889 B TW577889 B TW 577889B
Authority
TW
Taiwan
Prior art keywords
methyl
pyridine
chloro
lhf
imidazo
Prior art date
Application number
TW088121089A
Other languages
English (en)
Chinese (zh)
Inventor
Hiroshi Kayakiri
Yoshito Abe
Hitoshi Hamashima
Hitoshi Sawada
Naoki Ishibashi
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of TW577889B publication Critical patent/TW577889B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW088121089A 1998-12-04 1999-12-02 Sulfonamide compound having hypoglycemic activity or PDE-V inhibitory activity TW577889B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP34617598 1998-12-04
JP36754098 1998-12-24
JP25928399 1999-08-09

Publications (1)

Publication Number Publication Date
TW577889B true TW577889B (en) 2004-03-01

Family

ID=27334802

Family Applications (1)

Application Number Title Priority Date Filing Date
TW088121089A TW577889B (en) 1998-12-04 1999-12-02 Sulfonamide compound having hypoglycemic activity or PDE-V inhibitory activity

Country Status (15)

Country Link
US (2) US6573274B1 (cs)
EP (1) EP1136492A4 (cs)
KR (1) KR20010086593A (cs)
CN (1) CN1335847A (cs)
AR (1) AR021542A1 (cs)
AU (1) AU769890B2 (cs)
BR (1) BR9916919A (cs)
CA (1) CA2352871A1 (cs)
CZ (1) CZ20011981A3 (cs)
HK (1) HK1044154A1 (cs)
HU (1) HUP0104549A3 (cs)
IL (1) IL143439A0 (cs)
TR (1) TR200101568T2 (cs)
TW (1) TW577889B (cs)
WO (1) WO2000034277A1 (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL133575A0 (en) * 1997-06-27 2001-04-30 Fujisawa Pharmaceutical Co Sulfonamide compounds, a method for producing same and pharmaceutical compositions containing same
CN1446084A (zh) * 2000-08-11 2003-10-01 辉瑞大药厂 胰岛素抗性综合症的治疗
US7223785B2 (en) 2003-01-22 2007-05-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US7098231B2 (en) 2003-01-22 2006-08-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
TW200533336A (en) * 2004-03-02 2005-10-16 Fujisawa Pharmaceutical Co Concomitant drugs
NZ578561A (en) * 2007-02-06 2011-07-29 Cipla Ltd Process for the preparation of ethyl-n-(2,3-dichloro-6-nitrobenzyl) glycine hydrochloride
WO2014123203A1 (ja) * 2013-02-06 2014-08-14 京都薬品工業株式会社 糖尿病治療薬
GB201321741D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
TWI731317B (zh) * 2013-12-10 2021-06-21 美商健臻公司 原肌球蛋白相關之激酶(trk)抑制劑
MX2020009228A (es) 2018-03-08 2021-01-08 Incyte Corp Compuestos diolicos de aminopirazina como inhibidores de fosfoinositida 3-cinasas-gamma.
WO2020010003A1 (en) 2018-07-02 2020-01-09 Incyte Corporation AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215994A (en) * 1990-09-25 1993-06-01 Fujisawa Pharmaceutical Co., Ltd. Angiotenin II antagonizing heterocyclic derivatives
EP0503838A3 (en) * 1991-03-08 1992-10-07 Merck & Co. Inc. Heterocyclic compounds bearing acidic functional groups as angiotensin ii antagonists
US5128327A (en) 1991-03-25 1992-07-07 Merck & Co., Inc. Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle
WO1993019067A1 (en) * 1991-09-12 1993-09-30 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine derivatives as angiotensin ii antagonists
CN1211238A (zh) 1995-12-28 1999-03-17 藤泽药品工业株式会社 苯并咪唑衍生物
DE69826286T2 (de) 1997-06-27 2005-11-24 Fujisawa Pharmaceutical Co., Ltd. Derivate mit einem aromatischen ring
IL133575A0 (en) * 1997-06-27 2001-04-30 Fujisawa Pharmaceutical Co Sulfonamide compounds, a method for producing same and pharmaceutical compositions containing same

Also Published As

Publication number Publication date
CZ20011981A3 (cs) 2002-01-16
EP1136492A1 (en) 2001-09-26
HUP0104549A2 (hu) 2002-04-29
AU769890B2 (en) 2004-02-05
HK1044154A1 (zh) 2002-10-11
CN1335847A (zh) 2002-02-13
WO2000034277A1 (fr) 2000-06-15
AR021542A1 (es) 2002-07-24
AU1414100A (en) 2000-06-26
BR9916919A (pt) 2002-01-15
TR200101568T2 (tr) 2001-10-22
US20030171396A1 (en) 2003-09-11
KR20010086593A (ko) 2001-09-13
CA2352871A1 (en) 2000-06-15
IL143439A0 (en) 2002-04-21
US6573274B1 (en) 2003-06-03
EP1136492A4 (en) 2002-03-27
HUP0104549A3 (en) 2002-12-28
US6890934B2 (en) 2005-05-10

Similar Documents

Publication Publication Date Title
AU2021232806B2 (en) Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation
CN105073733B (zh) 蛋白激酶抑制剂
AU2006302135B2 (en) Kinase inhibitors
TWI567066B (zh) 蛋白質激酶抑制劑
AU774262B2 (en) Substituted pyrazoles as p38 kinase inhibitors
EP1812439B1 (en) Kinase inhibitors
AU2014241152A1 (en) Benzimidazolone derivatives as bromodomain inhibitors
CN105732614B (zh) 磺酰胺基芳基炔类化合物及其用途
US20080153869A1 (en) Kinase Inhibitors
ES2750791T3 (es) Derivados de indolizina como inhibidores de fosfoinositido 3-quinasas
OA12058A (en) 5-(2-Substituted-5-heterocyclylsulphonylpyrid-3-yl)-dihydropyrazoloÄ4,3-DÜpyrimidin-7-ones as phosphodiesterase inhibitors.
CA2887203A1 (en) 2,3-(hetero)aryl substituted pyridinyl compounds and their use as gdf-8 inhibitors
AU2012308570A1 (en) Indazole-3-carboxamides and their use as Wnt/b-catenin signaling pathway inhibitors
TW577889B (en) Sulfonamide compound having hypoglycemic activity or PDE-V inhibitory activity
CA2758958A1 (en) Substituted imidazo[1,2-a]pyridine derivatives, pharmaceutical compositions, and methods of use as .beta.-secretase inhibitors
KR20170098324A (ko) 특정 트리아졸로피리딘 및 트리아졸로피라진, 이들의 조성물 및 이들의 사용 방법
KR20170016465A (ko) PI3K 억제제로 사용되는 피리디노[1,2-a]피리미돈 유사체
FI93444C (fi) Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi
US20230227429A1 (en) Sulphonamide compounds
TW201144309A (en) Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators
WO2017108203A1 (en) Novel substituted indoline compounds as phosphodiesterase inhibitors
CN102887867B (zh) 一类三嗪类化合物、该化合物的制备方法及其用途
CN116655626B (zh) 一种含咪唑并[l,2-a]吡啶骨架的环丙二酰胺化合物及其制备方法和用途
MXPA01005374A (en) Sulfonamide compounds and uses thereof as medicines
OA17636A (en) Benzimidazolone derivatives as bromodomain inhibitors

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees